1-20 of 92
Thomas Pabst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic role of FDG-PET in outcomes of relapsed/refractory large B-cell lymphoma treated with CD3-CD20 directed bispecific antibodies

Free
Sophie Wollnitza, David Ventura, Marcel Teichert, Fabian Freisleben, Hristo Boyadzhiev, Robert Seifert, Michelle Amon, Julia Scholz, Alexander Pohlmann, Akhil Behringer, Philipp Backhaus, Philipp Schindler, Wolfgang Roll, Fabian Müller, Thomas Pabst, Michael Schaefers, Bastian von Tresckow, Evgenii Shumilov, Georg Lenz
Journal: Blood
Blood (2025) 146 (Supplement 1): 5518.
https://doi.org/10.1182/blood-2025-5518
Published: 2025
Journal Articles

Phase 1/2 study of MP0533, a tetra-specific T cell engager (CD33 x CD123 x CD70 x CD3), in patients with relapsed/refractory AML or MDS/AML: Initial results from optimized treatment regimen including densified MP0533 dosing and adapted premedication

Free
Pierre Bories, Mojca Jongen-Lavrencic, Laimonas Griškevičius, Thomas Pabst, David de Leeuw, Gerwin A. Huls, Nicolas Boissel, Arnaud Pigneux, Steffen Boettcher, Mariola Dymkowska, Christiane Andrieu, Elena Fernandez, Paul Baverel, Vaia Stavropoulou, Michael Sanderson, Vladimir Kirkin, Philippe Legenne, Marion Subklewe
Journal: Blood
Blood (2025) 146 (Supplement 1): 3419.
https://doi.org/10.1182/blood-2025-3419
Published: 2025
Journal Articles

Multiple time-point FDG-PET imaging for risk stratification of patients with relapsed/refractory large B-cell lymphoma undergoing CD19-directed CAR-T cell therapy

Free
Evgenii Shumilov, David Ventura, Valeria Carobin, Hristo Boyadzhiev, Simon Call, Wolfgang Roll, Philipp Backhaus, Akhil Behringer, Sophie Wollnitza, Julia Marx, Maximilian Seib, Alexander Pohlmann, Christian Reicherts, Matthias Stelljes, Philipp Schindler, Michelle Amon, Michael Schaefers, Thomas Pabst, Robert Seifert, Georg Lenz
Journal: Blood
Blood (2025) 146 (Supplement 1): 5491.
https://doi.org/10.1182/blood-2025-5491
Published: 2025
Journal Articles

Outcomes of multiple myeloma (MM) patients with del 17p as a sole high risk cytogenetic abnormality who underwent either single or tandem upfront autologous stem cell transplant approaches in EBMT centres between 2016 and 2022

Free
Conal Houstoun, Patrick Hayden, Dirk-Jan Eikema, Linda Koster, Sandra Sauer, Annoek Broers, Neil Rabin, Tobias Gedde-Dahl, Britta Besemer, Matthew Collin, Luisa Giaccone, Kristina Carlson, Thomas Pabst, Deborah Richardson, Jean Marc Schiano De Colella, Bertrand Arnulf, Mathias Hänel, Christine Schuermans, Francesco Zaja, Kavita Raj, Joanna Drozd-Sokolowska, Laurent Garderet, Nico Gagelmann, Meral Beksac, Donal McLornan
Journal: Blood
Blood (2025) 146 (Supplement 1): 4583.
https://doi.org/10.1182/blood-2025-4583
Published: 2025
Journal Articles

CAR T-cells or bispecific antibodies for relapsed/refractory multiple myeloma: Head-to-head real-world european comparison

Free
Maximilian Merz, Tomas Jelinek, Thomas Pabst, Raphael Teipel, Anca-Maria Albici, Bastian von Tresckow, Marcel Teichert, Uta Demel, Antonia Busse, Marie Wesener, Tobias A.W. Holderried, Friederike Schmitz, Fabian Müller, Friedrich-Linus Roessiger, Barbara Jeker, Michele Hoffmann, Natalie Schub, Natalia Tovar, Ben-Niklas Baermann, Stork Martin, Alexandra Jungova, Jiri Minarik, Jakub Radocha, Ivan Špička, Ludek Pour, Polona Novak, Klara Slajpah, Karla Rener, Matjaz Sever, Ulrich Keller, Stephan Bohl, Francis Ayuk, David Fandrei, Patrick Born, Vladan Vucinic, Nicolaus Kroeger, Irene Strassl, Friedrich Stoelzel, Roman Hajek, Carlos Fernandez de Larrea, Nico Gagelmann
Journal: Blood
Blood (2025) 146 (Supplement 1): 4590.
https://doi.org/10.1182/blood-2025-4590
Published: 2025
Journal Articles

Autologous stem cell transplantation versus consolidation chemotherapy as post-remission treatment in newly diagnosed favorable and intermediate risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials

Free
Dimitrios Kotsos, Carin Hazenberg, Thomas Pabst, Patrycja Gradowska, Markus Manz, Johan Maertens, Carlos Graux, Marie-Christiane Vekemans, Bjorn Gjertsen, Soren Lehmann, Catharina Van Elssen, Peter Valk, Edo Vellenga, Gert J. Ossenkoppele, Bob Lowenberg, Marc Raaijmakers, Gerwin A. Huls, Jurjen Versluis
Journal: Blood
Blood (2025) 146 (Supplement 1): 2517.
https://doi.org/10.1182/blood-2025-2517
Published: 2025
Journal Articles

Magrolimab plus azacitidine vs physician’s choice for untreated TP53 -mutated acute myeloid leukemia: the ENHANCE-2 study

Open Access
Clinical Trials & Observations
Joshua F. Zeidner, David A. Sallman, Christian Récher, Naval G. Daver, Anskar Y. H. Leung, Devendra K. Hiwase, Marion Subklewe, Thomas Pabst, Pau Montesinos, Richard A. Larson, Lindsay Wilde, Anoop K. Enjeti, Ichiro Kawashima, Cristina Papayannidis, Jenny O’Nions, Lisa Johnson, Mei Dong, Julie Huang, Taravat Bagheri, Gal Hacohen Kleiman, Calvin Lee, Paresh Vyas
Journal: Blood
Blood (2025) 146 (5): 590–600.
https://doi.org/10.1182/blood.2024027408
Published: 2025
Includes: Supplemental data
Journal Articles

Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

Free
Clinical Trials & Observations
Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K. Nooka, Salomon Manier, Natalie Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott Solomon, Ingerid Weum Abrahamsen, Rachid Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesús Berdeja, Sergio Giralt, Anna Truppel-Hartmann, Yanping Chen, Xiaobo Zhong, Fan Wu, Julia Piasecki, Laurie Eliason, Devender Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa McKiver, Paula Rodríguez-Otero
Journal: Blood
Blood (2024) 144 (23): 2389–2401.
https://doi.org/10.1182/blood.2024024582
Published: 2024
Includes: Supplemental data
Journal Articles

Therapy Management and Outcomes in Newly Diagnosed Unfit AML Patients Receiving Venetoclax + HMA - Insights from a Prospective Real-World Study in Switzerland and Austria

Free
Thomas Pabst, Thomas Lehmann, Petra Pichler, Sigrid Machherndl-Spandl, Michael Gregor, Jeroen S. Goede, Sabine Gerull, Daniel Maria Mayer, Jean-François Lambert, Catherine Germanier, Georg Stüssi
Journal: Blood
Blood (2024) 144 (Supplement 1): 2413.
https://doi.org/10.1182/blood-2024-193999
Published: 2024
Journal Articles

Efficacy of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed/Refractory Multiple Myeloma and Prior Central Nervous System Manifestation: A Retrospective Real-World Analysis

Free
Markus Maulhardt, Philipp Berning, Christine Hanoun, Hristo Boyadzhiev, Anca Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Simon Call, Natalie Schub, Enver Aydilek, Michael Daskalakis, Wolfram Jung, Justin Hasenkamp, Carolin Krekeler, Cyrus Khandanpour, Ulrike Bacher, Hans Christian Reinhardt, Georg Lenz, Friedrich Stölzel, Gerald Wulf, Thomas Pabst, Bastian von Tresckow, Evgenii Shumilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 4759.
https://doi.org/10.1182/blood-2024-202467
Published: 2024
Journal Articles

Idecabtagene Vicleucel (ide-cel) Shows Similar Efficacy and Toxicity in Patients with Multiple Myeloma Aged 70 and Older Compared to Younger Patients: A Multicenter Cohort Study

Free
Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, Anca Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Christian R Schultze-Florey, Simon Call, Natalie Schub, Annamaria Brioli, Michael Daskalakis, Juliane Knust, Justin Hasenkamp, Matthias Stelljes, Cyrus Khandanpour, Ulrike Bacher, Christine Hanoun, Florian Heidel, Hans Christian Reinhardt, Georg Lenz, Gerald Wulf, Friedrich Stölzel, Bastian von Tresckow, Thomas Pabst, Evgenii Shumilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 3383.
https://doi.org/10.1182/blood-2024-198763
Published: 2024
Journal Articles

Cilta-Cel Is Associated with Improved Outcomes and Distinct Cellular Dynamics Compared with Ide-Cel for Relapsed or Refractory Multiple Myeloma

Free
Nico Gagelmann, Friedrich Stölzel, Roland Fenk, Tobias A.W. Holderried, Fabian Mueller, Natalia Tovar, Aina Oliver-Caldés, Kristin Rathje, Vladan Vucinic, Soraya Kharboutli, Ben-Niklas Bärmann, Francis A. Ayuk, Uwe Platzbecker, Anca Maria Albici, Natalie Schub, Friederike Schmitz, Cyrus Khandanpour, Marcel Teichert, Barbara Jeker, Nicolaus Kroeger, Bastian von Tresckow, Carlos Fernandez de Larrea, Thomas Pabst, Maximilian Merz
Journal: Blood
Blood (2024) 144 (Supplement 1): 2003.
https://doi.org/10.1182/blood-2024-211410
Published: 2024
Journal Articles

MP0533 (CD33 x CD123 x CD70 x CD3), a Tetra-Specific CD3-Engaging Darpin for the Treatment of Patients with Relapsed/Refractory AML or MDS/AML: Results of an Ongoing Phase 1/2a Study

Free
Mojca Jongen-Lavrencic, Thomas Pabst, Pierre Bories, Laimonas Griškevičius, Gerwin Huls, David C. de Leeuw, Steffen Boettcher, Arnaud Pigneux, Nicolas Boissel, Mariola Dymkowska, Christiane Andrieu, Oliver Schönborn-Kellenberger, Paul G. Baverel, Zita Arany, Elena Fernandez, Ana-Maria Florescu, Michael P. Sanderson, Anne Goubier, Vladimir Kirkin, Philippe Legenne, Marion Subklewe
Journal: Blood
Blood (2024) 144 (Supplement 1): 2881.
https://doi.org/10.1182/blood-2024-199211
Published: 2024
Journal Articles

Trial in Progress: A Multicenter, Open Label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients Who Are Not Candidates for Intensive Therapy

Free
Gail J. Roboz, Ahmed Aribi, Adrian Ochsenbein, Carsten Riether, Monic J. Stuart, Emily Mitchell, Komal Changela, Adam George, Michael Boyiadzis, Clayton Smith, Thomas Pabst
Journal: Blood
Blood (2024) 144 (Supplement 1): 1504.2.
https://doi.org/10.1182/blood-2024-202648
Published: 2024
Journal Articles

Time of CAR-T Failure Is a Strong Predictor of Outcome for Bispecific Antibody Therapy in Relapsed/Refractory Large B-Cell Lymphoma

Free
Evgenii Shumilov, Rebecca Wurm-Kuczera, Vladan Vucinic, Maximilian Seib, Udo Holtick, Paolo Mazzeo, Julia Katharina Scholz, Hristo Boyadzhiev, Thomas Melchardt, Alexander Hölscher, Christian R Schultze-Florey, Giuliano Filippini Velazquez, Anna Ossami Saidy, Vadim Lesan, Ulf Schnetzke, Andrea Kerkhoff, Ulrike Bacher, Susanne Ghandili, Enver Aydilek, Niklas Gebauer, Thomas Weber, Gerald Wulf, Bertram Glass, Lorenz Thurner, Florian Heidel, Christoph Schmid, Andreas Viardot, Mathias Hänel, Sascha Dietrich, Thomas Pabst, Francis A. Ayuk, Bastian von Tresckow, Björn Chapuy, Christiane Pott, Fabian Mueller, Georg Lenz
Journal: Blood
Blood (2024) 144 (Supplement 1): 114.
https://doi.org/10.1182/blood-2024-198883
Published: 2024
Journal Articles

Real-World Outcomes of CD19-Targeted CAR T-Cell Therapy in Adult and Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Insights from the GoCART Coalition on Behalf of the PDWP, ALWP, and CTIWP of the EBMT

Free
Valentin Ortiz-Maldonado, Jacques-Emmanuel Galimard, Giorgio Ottaviano, Anna Alonso-Saladrigues, Shatha Y. Farhan, Sowjanya Vuyyala, Eva Michel, Fizza Imran, Nazaret Sánchez-Sierra, Nuria Martínez-Cibrián, Samppa Ryhänen, Sr., Richard Mitchell, Stephan Mielke, Soeren Lykke Petersen, Anne Sirvent, Thomas Pabst, Jurgen Kuball, Pere Barba, Antonio Perez, Andishe Attarbaschi, Arnon Nagler, Jose Antonio Pérez-Simón, Malte von Bonin, Emma Nicholson, David Beauvais, Julio Delgado, Susana Rives, Krzysztof Kalwak, Fabio Ciceri, Annalisa Ruggeri, Adriana Balduzzi, Sebastian Giebel
Journal: Blood
Blood (2024) 144 (Supplement 1): 2333.
https://doi.org/10.1182/blood-2024-206032
Published: 2024
Journal Articles

Outcomes of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Multicenter Real-World Analysis

Free
Philipp Berning, David Baden, Philipp Faustmann, Snjezana Janjetovic, Hanna Katharina Zieger, Jan Christian Schroeder, Giuliano Filippini Velazquez, Anna Ossami Saidy, Hristo Boyadzhiev, Tim Sauer, Jan-Henrik Mikesch, Niklas Gebauer, Susanne Ghandili, Paul J. Bröckelmann, Friederike Hildebrand, Veit L. Buecklein, Rebecca Wurm-Kuczera, Ulrich Keller, Georg Lenz, Thomas Pabst, Thomas Melchardt, Claudia Lengerke, Maher Hanoun, Evgenii Shumilov, Ulrike Bacher
Journal: Blood
Blood (2024) 144 (Supplement 1): 3818.
https://doi.org/10.1182/blood-2024-211227
Published: 2024
Journal Articles

Boosting CAR T cells against lymphomas

Free
Thomas Pabst, Ulrike Bacher
Journal: Blood
Blood (2024) 144 (7): 689–691.
https://doi.org/10.1182/blood.2024025378
Published: 2024
Journal Articles

Idecabtagene Vicleucel (ide-cel) Versus Standard (std) Regimens in Patients (pts) with Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Updated Analysis from KarMMa-3

Free
Paula Rodríguez Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Michele Cavo, Ajay K. Nooka, Salomon Manier, Natalie S. Callander, Luciano Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R. Solomon, Ingerid Weum Abrahamsen, Rachid Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur S. Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesus G. Berdeja, Anna Truppel-Hartmann, Rashmi Bhatnagar, Fan Wu, Julia Piasecki, Laurie Eliason, Devender Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa-McKiver, Sergio A. Giralt
Journal: Blood
Blood (2023) 142 (Supplement 1): 1028.
https://doi.org/10.1182/blood-2023-178933
Published: 2023
Journal Articles

The Laip-Based-Dfn Approach Is Superior in Terms of Useful MRD Results As Compared to the Laip Approach after Cycle II in Acute Myeloid Leukemia

Free
Lok Lam Ngai, Diana Hanekamp, Angèle Kelder, Willemijn Scholten, Jannemieke Carbaat-Ham, Mona M.H.E Fayed, Alexander N. Snel, Costa Bachas, Jesse M. Tettero, Tim R. Mocking, Vincent H.J. Van Der Velden, Jennichjen Slomp, Willemijn Hobo, Dimitri Breems, Thomas Fischer, Bjorn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Thomas Pabst, Jakob Passweg, Sr., Kimmo Porkka, Peter J. M. Valk, Patrycja Gradowska, Bob Löwenberg, David C. de Leeuw, Arjan A. van de Loosdrecht, Gert Ossenkoppele, Jacqueline Cloos
Journal: Blood
Blood (2023) 142 (Supplement 1): 1572.
https://doi.org/10.1182/blood-2023-181709
Published: 2023